Release Date: 31/07/18 12:57 Summary: Edison Report Retraction of Statements Price Sensitive: Yes Download Document 354.28KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%